Platelet Rich Plasma Market : ToC

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Platelet Rich Plasma: Market Snapshot
3.2 Global Market Share Analysis by Region, 2015
3.3 Global Platelet-Rich Plasma Market: Opportunity Map

Section 4 Market Overview
4.1 Product Overview
4.2 Global Platelet-Rich Plasma Market: Key Industry Developments
4.3 Global Platelet-Rich Plasma Market: Market Indicators

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
      5.2.1 Increasing incidence of orthopedic and sports injuries
      5.2.2 Rising number of cosmetic surgical procedures
      5.2.3 Technological advancements and regulatory approvals for new devices
      5.2.4 Increasing popularity of PRP products and treatments
      5.2.5 Growing awareness about Platelet-Rich Plasma therapies
5.3 Restraints
      5.3.1 Standardization in quality of allergen extracts
      5.3.2 Difficulty in quality control of test results
5.4 Opportunities
      5.4.1 Ultrasound & Platelet Rich Plasma Therapy
      5.4.2 Advances in Technology & Devices will open new avenues
5.5 Porters Analysis
5.6 Value Chain Analysis 
5.7 Platelet-Rich Plasma Market Outlook

Section 6 Platelet-Rich Plasma Market Analysis, by Type 
6.1 Key Findings
6.2 Introduction
6.3 Global Platelet-Rich Plasma Market Value Share Analysis, by Type 
6.4 Platelet-Rich Plasma Market Forecast, by Type 
6.5 Platelet-Rich Plasma Market Analysis, by Type 
      6.5.1 Pure-PRP
      6.5.2 Leukocyte-rich-PRP
      6.5.3 Pure-PRF
6.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Type 
6.7 Key Trends

Section 7 Platelet-Rich Plasma Market Analysis, by Origin
7.1 Key Findings
7.2 Introduction
7.4 Platelet-Rich Plasma Market Forecast, by Origin
7.5 Platelet-Rich Plasma Market Analysis, by Origin
      7.5.1 Autologous PRP
      7.5.2 Allogeneic PRP
      7.5.3 Homologous PRP
7.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Origin
7.7 Key Trends

Section 8 Platelet-Rich Plasma Market Analysis, by Applications 
8.1 Key Findings
8.2 Introduction
8.3 Global Platelet-Rich Plasma Market Value Share Analysis, by Applications 
8.4 Platelet-Rich Plasma Market Forecast, by Applications 
8.5 Platelet-Rich Plasma Market Analysis, by Applications 
      8.5.1 Orthopedic Surgery
      8.5.2 Cosmetic Surgery
      8.5.3 General Surgery 
      8.5.4 Neurosurgery
      8.5.5 Others
8.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Applications 

Section 9 Platelet-Rich Plasma Market Analysis, by Region
9.1 Global Platelet-Rich Plasma Market Snapshot, by Country
9.2 Global Platelet-Rich Plasma Market Value Share Analysis, by Region
9.3 Platelet-Rich Plasma Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region

Section 10 North America Platelet-Rich Plasma Market Analysis
10.1 Key Findings
10.2 Market Overview
10.3 Market Analysis, by Country
      10.3.1 North America Market Value Share Analysis, by Country
      10.3.2 North America Market Forecast by Country
10.4 Market Analysis, by Type
      10.4.1 North America Market Value Share Analysis, by Type 
      10.4.2 North America Market Forecast, by Type 
10.5 Market Analysis, by Origin 
      10.5.1 North America Market Value Share Analysis, by Origin 
      10.5.2 North America Market Forecast, by Origin 
10.6 Market Analysis, by Applications
      10.6.1 North America Market Value Share Analysis, by Applications 
      10.6.2 North America Market Forecast, by Applications 
10.7 North America Market Attractiveness Analysis
      10.7.1 By Type
      10.7.2 By Origin 
      10.7.3 By Applications
10.8 Market Trends

Section 11 Europe Platelet-Rich Plasma Market Analysis
11.1 Key Findings 
11.2 Market Overview
11.3 Market Analysis, by Country
      11.3.1 Europe Market Value Share Analysis, by Country
      11.3.2 Europe Market Forecast by Country
11.4 Market Analysis, by Type
      11.4.1 Europe Market Value Share Analysis, by Type 
      11.4.2 Europe Market Forecast, by Type 
11.5 Market Analysis, by Origin 
      11.5.1 Europe Market Value Share Analysis, by Origin 
      11.5.2 Europe Market Forecast, by Origin 
11.6 Market Analysis, by Applications
      11.6.1 Europe Market Value Share Analysis, by Applications
      11.6.2 Europe Market Forecast, by Applications 
11.7 Europe Market Attractiveness Analysis
      11.7.1 By Type
      11.7.2 By Origin
      11.7.3 By Applications
11.8 Market Trends

Section 12 Asia Pacific Platelet-Rich Plasma Market Analysis
12.1 Key Findings
12.2 Market Overview
12.3 Market Analysis, by Country
      12.3.1 Asia Pacific Market Value Share Analysis, by Country
      12.3.2 Asia Pacific Market Forecast by Country
12.4 Market Analysis, by Type
      12.4.1 Asia Pacific Market Value Share Analysis, by Type 
      12.4.2 Asia Pacific Market Forecast, by Type 
12.5 Market Analysis, by Origin 
      12.5.1 Asia Pacific Market Value Share Analysis, by Origin 
      12.5.2 Asia Pacific Market Forecast, by Origin 
12.6 Market Analysis, by Applications      
      12.6.1 Asia Pacific Market Value Share Analysis, by Applications 
      12.6.2 Asia Pacific Market Forecast, by Applications 
12.7 Asia Pacific Market Attractiveness Analysis
      12.7.1 By Type
      12.7.2 By Origin 
      12.7.3 By Applications
12.8 Market Trends

Section 13 Latin America Platelet-Rich Plasma Market Analysis
13.1 Key Findings
13.2 Market Overview
13.3 Market Analysis, by Country
      13.3.1 Latin America Market Value Share Analysis, by Country
      13.3.2 Latin America Market Forecast by Country
13.4 Market Analysis, by Type
      13.4.1 Latin America Market Value Share Analysis, by Type 
      13.4.2 Latin America Market Forecast, by Type 
13.5 Market Analysis, by Origin 
      13.5.1 Latin America Market Value Share Analysis, by Origin 
      13.5.2 Latin America Market Forecast, by Origin 
13.6 Market Analysis, by Applications
      13.6.1 Latin America Market Value Share Analysis, by Applications
      13.6.2 Latin America Market Forecast, by Applications 
13.7 Latin America Market Attractiveness Analysis
      13.7.1 By Type
      13.7.2 By Origin 
      13.7.3 By Applications
13.8 Market Trends

Section 14 MEA Platelet-Rich Plasma Market Analysis
14.1 Key Findings
14.2 Market Overview
14.3 Market Analysis, by Country
      14.3.1 MEA Market Value Share Analysis, by Country
      14.3.2 MEA Market Forecast by Country 
14.4 Market Analysis, by Type
      14.4.1 MEA Market Value Share Analysis, by Type 
      14.4.2 MEA Market Forecast, by Type 
14.5 Market Analysis, by Origin 
      14.5.1 MEA Market Value Share Analysis, by Origin 
      14.5.2 MEA Market Forecast, by Origin 
14.6 Market Analysis, by Applications
      14.6.1 MEA Market Value Share Analysis, by Applications
      14.6.2 MEA Market Forecast, by Applications 
14.7 MEA Market Attractiveness Analysis
      14.7.1 By Type
      14.7.2 By Origin 
      14.7.3 By Applications
14.8 Market Trends

Section 15 Company Profiles
15.1 Global Platelet-Rich Plasma Market Share Analysis, by Company (2015) 
15.2 Competition Matrix
15.3 Company Profiles
      15.3.1 Harvest Technologies Corporation
                15.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.1.2 Financial Overview
                15.3.1.3 Product Portfolio
                15.3.1.4 SWOT Analysis
                15.3.1.5 Strategic Overview
      15.3.2 Arthrex, Inc.
                15.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.2.2 Financial Overview
                15.3.2.3 Product Portfolio
                15.3.2.4 SWOT Analysis
                15.3.2.5 Strategic Overview
      15.3.3 Zimmer Biomet 
                15.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.3.2 Financial Overview
                15.3.3.3 Product Portfolio
                15.3.3.4 SWOT Analysis
                15.3.3.5 Strategic Overview
      15.3.4 DePuy Synthes, Inc.
                15.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.4.2 Financial Overview
                15.3.4.3 Product Portfolio
                15.3.4.4 SWOT Analysis
                15.3.4.5 Strategic Overview
      15.3.5 Stryker Corporation
                15.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.5.2 Financial Overview
                15.3.5.3 Product Portfolio
                15.3.5.4 SWOT Analysis
                15.3.5.5 Strategic Overview
      15.3.6 AdiStem Ltd.
                15.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.6.2 Financial Overview
                15.3.6.3 Product Portfolio
                15.3.6.4 SWOT Analysis
                15.3.6.5 Strategic Overview
      15.3.7 ISTO Biologics
                15.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.7.2 Financial Overview
                15.3.7.3 Product Portfolio
                15.3.7.4 SWOT Analysis
                15.3.7.5 Strategic Overview
      15.3.8 Cesca Therapeutics, Inc.
                15.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.8.2 Financial Overview
                15.3.8.3 Product Portfolio
                15.3.8.4 SWOT Analysis
                15.3.8.5 Strategic Overview
      15.3.9 Emcyte Corporation
                15.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.9.2 Financial Overview
                15.3.9.3 Product Portfolio
                15.3.9.4 SWOT Analysis
                15.3.9.5 Strategic Overview
      15.3.10 Nuo Therapeutics
                15.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.10.2 Financial Overview
                15.3.10.3 Product Portfolio
                15.3.10.4 SWOT Analysis
                15.3.10.5 Strategic Overview
      15.3.11 Exactech Inc.
                15.3.11.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.11.2 Financial Overview
                15.3.11.3 Product Portfolio
                15.3.11.4 SWOT Analysis
                15.3.11.5 Strategic Overview
      15.3.12 Regen Lab SA 
                15.3.12.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.12.2 Financial Overview
                15.3.12.3 Product Portfolio
                15.3.12.4 SWOT Analysis
                15.3.12.5 Strategic Overview